eo-3021
elevation oncology
['eo-3021', 'elevation oncology']
new preclinical data from eo-3021, our antibody drug conjugate (#adc) in development, was presented at #aacr23 demonstrating the investigational therapy s safety and efficacy. learn more about our presentation: $elev 
We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.